Medium materiality6/10
Acadia Pharmaceuticals price target raised to $38 from $37 at Deutsche Bank
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Deutsche Bank raises ACAD target to $38; posted price $30.31; price change +0.27 since signal.
- Target up to $38; price $30.31.
Key facts
- 01
Target: $38
- 02
Posted price: $30.31
- 03
Analyst firm: Deutsche Bank
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.